FDA warns against use of Pfizer's Revatio in children

Administrator 58 Reuters Health
Print Email

(Reuters) - U.S. health regulators recommended against use of Pfizer Inc's pulmonary arterial hypertension (PAH) drug Revatio in children up to 17 years of age, saying it had a higher risk of death when taken in a high dose.




Read Full Article


x

You can contact us at:
info@realtruthtalks.com